Anticorps Polyclonal de lapin anti-ITM2C
ITM2C Polyclonal Antibody for IHC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
IHC, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 13601-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
13601-1-PBS cible ITM2C dans les applications de IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | ITM2C Protéine recombinante Ag3876 |
Nom complet | integral membrane protein 2C |
Masse moléculaire calculée | 230aa,26 kDa; 267aa,30 kDa |
Poids moléculaire observé | 30 kDa |
Numéro d’acquisition GenBank | BC025742 |
Symbole du gène | ITM2C |
Identification du gène (NCBI) | 81618 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
The Integral membrane protein 2C (ITM2C) is a type II integral transmembrane protein belonging to a family composed of at least two other members, ITM2A and ITM2B. ITM2C, often called transmembrane protein BRI3, is highly expressed in brain tissue. Yeast two-hybrid screen system revealed that BRI3 could interact with beta-secretase beta-amyloid protein converting enzyme (BACE)1 and the microtubule-destabilizing protein SCG10 (STMN2). It may play a role in TNF-induced cell death and neuronal differentiation. BRI3 was found to inhibit the various processing of amyloid precursor protein (APP) by blocking the access of alpha- and beta-secretases to APP, competitive inhibition of APP processing by BRI3 may provide a new approach to Alzheimer disease (AD) therapy and prevention.